AIM ImmunoTech

-$0.04 (-2.08%) As of 4:08 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.

CEO
Thomas Kenwood Equels
Employees
23
Headquarters
Ocala, Florida
Founded
1966

AIM Key Statistics

Market Cap
90.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.25K
High Today
$1.91
Low Today
$1.88
Open Price
$1.90
Volume
162.20K
52 Week High
$3.06
52 Week Low
$1.65

AIM Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure